Literature DB >> 2598924

Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities.

D Carling1, P R Clarke, V A Zammit, D G Hardie.   

Abstract

1. We have purified the AMP-activated protein kinase 4800-fold from rat liver. The acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA(HMG-CoA) reductase kinase activities copurify through all six purification steps and are inactivated with similar kinetics by treatment with the reactive ATP analogue fluorosulphonylbenzoyladenosine. 2. The final preparation contains several polypeptides detectable by SDS/polyacrylamide gel electrophoresis, but only one of these, with an apparent molecular mass of 63 kDa, is labelled using [14C]fluorosulphonylbenzoyladenosine. This is also the only polypeptide in the preparation that becomes significantly labelled during incubation with [gamma 32P]ATP. This autophosphorylation reaction did not affect the AMP-stimulated kinase activity. 3. In the absence of AMP the purified kinase has apparent Km values for ATP and acetyl-CoA carboxylase of 86 microM and 1.9 microM respectively. AMP increases the Vmax 3-5-fold without a significant change in the Km for either protein or ATP substrates. 4. The response to AMP depends on the ATP concentration in the assay, but at a near-physiological ATP concentration the half-maximal effect of AMP occurs at 14 microM. Studies with a range of nucleoside monophosphates and diphosphates, and AMP analogues showed that the allosteric activation by AMP was very specific. ADP gave a small stimulation at low concentrations but was inhibitory at high concentrations. 5. These results show that the AMP-activated protein kinase is the major HMG-CoA reductase kinase detectable in rat liver under our assay conditions and that it is therefore likely to be identical to previously described HMG-CoA reductase kinase(s) which are activated by adenine nucleotides and phosphorylation. The AMP-binding and catalytic domains of the kinase are located on a 63-kDa polypeptide which is subject to autophosphorylation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598924     DOI: 10.1111/j.1432-1033.1989.tb15186.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  120 in total

1.  Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.

Authors:  P C Cheung; I P Salt; S P Davies; D G Hardie; D Carling
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Preconditioning induces sustained neuroprotection by downregulation of adenosine 5'-monophosphate-activated protein kinase.

Authors:  V R Venna; J Li; S E Benashski; S Tarabishy; L D McCullough
Journal:  Neuroscience       Date:  2011-11-18       Impact factor: 3.590

3.  Oncogene-induced senescence results in marked metabolic and bioenergetic alterations.

Authors:  Celia Quijano; Liu Cao; Maria M Fergusson; Hector Romero; Jie Liu; Sarah Gutkind; Ilsa I Rovira; Robert P Mohney; Edward D Karoly; Toren Finkel
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

4.  Cancer metabolism: Tumour friend or foe.

Authors:  Robert U Svensson; Reuben J Shaw
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

Review 5.  AMP-activated protein kinase and its downstream transcriptional pathways.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

6.  Ligand-regulated peptide aptamers that inhibit the 5'-AMP-activated protein kinase.

Authors:  Russell A Miller; Brock F Binkowski; Peter J Belshaw
Journal:  J Mol Biol       Date:  2006-07-26       Impact factor: 5.469

7.  Subunit and domain requirements for adenylate-mediated protection of Snf1 kinase activation loop from dephosphorylation.

Authors:  Dakshayini G Chandrashekarappa; Rhonda R McCartney; Martin C Schmidt
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

8.  AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

Authors:  Santiago Vernia; M Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Teresa Rubio; Luisa García-Haro; Marc Foretz; Santiago Rodríguez de Córdoba; Pascual Sanz
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

9.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

10.  Role of AMP-activated protein kinase in mechanism of metformin action.

Authors:  G Zhou; R Myers; Y Li; Y Chen; X Shen; J Fenyk-Melody; M Wu; J Ventre; T Doebber; N Fujii; N Musi; M F Hirshman; L J Goodyear; D E Moller
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.